Berna Uzunoğlu

Berna Uzunoğlu

Auto-generated profile, based on publicly available information

Berna Uzunoğlu

Department of Pediatric Allergy and Immunology, Izmir Tepecik Research and Training Hospital İzmir Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Pediatric Pulmonology
Verified
Journal Article
Closed access
BUBerna Uzunoğlu
Berna Uzunoğlu
EFEmre Fırat
Emre Fırat
IKİrEm Karadeniz
İrEm Karadeniz
FÇFigen Çelebi Çelik
Figen Çelebi Çelik
CKCanan Şule Ünsal Karkıner
Canan Şule Ünsal Karkıner
DCDemet Can
Demet Can

23 December 2025 in European Journal of Rhinology and Allergy
Verified
Journal Article
Closed access
ECErtuğrul Canlı
Ertuğrul Canlı
BUBerna Uzunoğlu
Berna Uzunoğlu
SESultan Eser
Sultan Eser
DCDemet Can
Demet Can
Purpose: There is a lack of sufficient research on the prevalence of sleep-related disordered breathing (SRDB) in children in Turkey. This study aimed to investigate the prevalence of habitual snoring and SRBD among schoolchildren in the city center of Balıkesir, located in the Northern Aegean region, using a Pediatric Sleep Questionnaire. Materials and Methods: This single-center, cross-sectional, prospective study was conducted between January and May 2022. The study targeted children aged 5 to 13 years attending preschools, primary and lower secondary schools in the center of Balıkesir/Turkey. Using simple random sampling, 13 schools were selected. From these schools, systematic sampling was used to recruit students. The Pediatric Sleep Questionnaire (PSQ) was distributed to the parents of 1300 students. Results: A total of 856 children (66%) whose families returned properly completed questionnaires were included in the study. The prevalence of habitual snoring was 5.6%, while SRBD was identified in 9.1% of the children aged 5 to 13. Gender and age had no statistically significant effect on the prevalence of SRDB or habitual snoring (p > 0.05). Witnessed sleep apnea was reported in 2.3% of children and was positively correlated with both habitual snoring (p = 0.001) and SRDB (p < 0.001). Morbidities such as enuresis nocturna, morning headaches, growth retardation, and attention-deficit/hyperactivity disorder (ADHD) were more frequently observed in both the habitual snoring and SRDB groups (p < 0.05). Conclusion: Screening through school-based surveys and questionnaires can enhance awareness of habitual snoring and SRDB. Considering the limited accessibility to sleep laboratories and the high cost of polysomnography worldwide, validated sleep questionnaires may serve as effective screening tools.

13 August 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
FCFigen Celebi Celik
Figen Celebi Celik
AKAlp Kazancioğlu
Alp Kazancioğlu
SGSoner Günder
Soner Günder
MOMeli̇kE Ocak
Meli̇kE Ocak
BUBerna Uzunoğlu
Berna Uzunoğlu
ÜŞÜmi̇t Murat Şahi̇nEr
Ümi̇t Murat Şahi̇nEr
Background/aim: This study aimed to evaluate the frequency, timing, severity, and clinical predictors of systemic reactions in children receiving subcutaneous allergen-specific immunotherapy (SCIT) with house dust mite (HDM) and grass pollen extracts under real-world clinical conditions. Materials and methods: This multicenter retrospective study included 623 children with moderate-to-severe allergic rhinitis, with or without asthma, who received SCIT between 2006 and 2023 at two tertiary pediatric allergy centers. Clinical characteristics, laboratory findings, immunotherapy protocols, and systemic reactions (SRs) were recorded and graded according to the updated 2024 World Allergy Organization (WAO) systemic reaction scale. Results: SCIT was well tolerated. Systemic reactions occurred in 10.7%, corresponding to 0.27% per injection. Most SRs were mild-to-moderate (WAO grades 1–2), and approximately three-quarters occurred during the maintenance phase. A progressive decline in SR incidence was observed throughout the treatment period. In the pollen SCIT subgroup, asthma was the only independent predictor of SRs (OR, 2.35; 95% CI 1.13–4.88; p = 0.022). No life-threatening reactions or fatalities were observed. Conclusion: Pediatric SCIT with pollen and HDM extracts demonstrated a favorable safety profile, with infrequent and predominantly nonsevere systemic reactions. The association between asthma and SRs in pollen SCIT highlights the importance of optimal asthma control throughout immunotherapy.

1 January 2026 in Congenital Anomalies
Verified
Journal Article
Closed access
BUBerna Uzunoğlu
Berna Uzunoğlu
NKNilgün Kurucu
Nilgün Kurucu
TKTezer Kutluk
Tezer Kutluk
HŞHilal Susam Şen
Hilal Susam Şen
GAGüzide Burça Aydın
Güzide Burça Aydın
AVAli Varan
Ali Varan